Nymox Pharmaceutical
NYMX
#9937
Rank
C$25.9 M
Marketcap
Country
$0.28
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -C$2.91 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -C$9.27 Million, an increase over its 2021 earnings that were of -C$17.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$2.91 Million-68.62%
2022 -C$9.27 Million-47.71%
2021 -C$17.72 Million6.61%
2020 -C$16.62 Million-10.91%
2019 -C$18.65 Million24.24%
2018 -C$15.02 Million-20.03%
2017 -C$18.78 Million2.71%
2016 -C$18.28 Million-63.86%
2015 -C$50.58 Million674.44%
2014 -C$6.54 Million-6.11%
2013 -C$6.96 Million-35.66%
2012 -C$10.82 Million-20.76%
2011 -C$13.65 Million38.33%
2010 -C$9.87 Million35.59%
2009 -C$7.28 Million11.8%
2008 -C$6.51 Million-12.94%
2007 -C$7.48 Million8.85%
2006 -C$6.87 Million36.5%
2005 -C$5.03 Million-4.4%
2004 -C$5.27 Million-14.58%
2003 -C$6.16 Million
2001 -C$4.52 Million-20.54%
2000 -C$5.69 Million21.72%
1999 -C$4.68 Million-25.56%
1998 -C$6.28 Million101.3%
1997 -C$3.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$9.62 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.85 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.57 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.40 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.75 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA